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The use of percutaneous angioplasty with subsequent intravascular metallic stent placement has gained increasing
acceptance over the past decade. Infections of these stents appear to be uncommon; however, the rarity of this
complication may in part be the result of a lack of availability of long-term follow-up data. A number of examples of
infected cardiac and peripheral vascular stents have been reported, often with fatal consequences. Herein, we report a
74-year-old woman who underwent subclavian and brachiocephalic artery angioplasty and stent placement for symp-
tomatic stenoses. Six months after the initial intervention, the patient returned with restenosis of the stents and
underwent repeat angioplasty to restore full patency. Two weeks later, the patient was readmitted with generalized
malaise and multiple erythematous, macular lesions on the right forearm and hand. Blood cultures grew Staphylococcus
aureus, and a computed tomographic scan of the chest showed a large brachiocephalic artery pseudoaneurysm with
surrounding hematoma. Despite prompt surgical intervention, this complication proved ultimately fatal. Infections of
metallic endovascular stents are potentially life-threatening complications and must be addressed urgently, including
possible surgical intervention. (J Vasc Surg 2002;36:625-8.)
Percutaneous angioplasty with placement of intravas-
cular metallic stents is now a widely accepted option for
treatment of vascular occlusive disease. Well-known com-
plications of these stents include intimal dissection, throm-
bosis, and malpositioning.1,2 Infection is still considered a
rare complication, despite an increasing number of reports
describing arteritis associated with infected stents,1-8 often
with fatal outcome from rupture of the affected vessel
caused by pseudoaneurysm formation around the infected
foreign body. Although most reports conclude with a rec-
ommendation for prophylactic antibiotics at the time of the
initial procedure and for any later endovascular manipula-
tions, this practice is still not widely accepted. Herein is
reported the case of a patient in whom an infection devel-
oped associated with brachiocephalic and subclavian artery
metallic stents after repeat angioplasty, with an ultimately
fatal outcome despite aggressive medical and surgical inter-
ventions.
CASE REPORT
A 74-year-old woman was seen in January 2001 with 3 weeks
of progressive pain and discoloration in the right hand, with the
right index finger having turned black. Medical history was notable
for a 50 pack-year history of smoking but no known prior history of
peripheral vascular disease. On physical examination, the patient
was found to have a mummified right index finger with only a
weakly audible right radial artery Doppler signal. Arteriography
showed a 75% stenosis of the proximal right subclavian artery, with
a 30% stenosis more distally (Fig 1 , A). In addition, a 65% stenosis
was noted in the brachiocephalic artery at its origin from the aortic
arch, and the right radial artery was occluded. Tandem 10  40
mm Smart stents were placed successfully via the left femoral artery
into the subclavian stenoses, and a Palmaz 294 stent was placed
into the brachiocephalic artery at its origin. Completion arteriog-
raphy confirmed optimal positioning of the stents with restoration
of blood flow. The patient underwent amputation of the distal
phalanx of the right index finger 2 days later. The patient recovered
promptly and was discharged home in stable condition on clopi-
dogrel bisulfate and aspirin therapy with a strong recommendation
to discontinue smoking.
In July 2001, the patient returned with new ischemic symptoms
of the right third finger, which was erythematous with blistering. The
patient had continued smoking and had neglected to take the anti-
platelet medications. Angiography showed severe restenosis, presum-
ably from intimal hyperplasia, in the stented brachiocephalic and right
subclavian arteries (Fig 1 , B). Repeat balloon angioplasty was per-
formed with marked improvement in blood flow. The patient was
again placed on aspirin and clopidogrel bisulfate therapy and was
discharged in stable condition. Of note, no antibiotics were used
during either angiographic procedure, which is standard protocol for
stent placement at our institution.
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Two weeks later, the patient had generalized weakness and
malaise, along with pain, redness, and swelling of the right hand.
The patient was first admitted to a neighboring hospital where
blood cultures grew Staphylococcus aureus. Vancomycin hydro-
chloride therapy was begun, and the patient was transferred to our
institution. Physical examination showed petechiae consistent with
septic emboli throughout the palm of the right hand and forearm,
which were swollen and inflamed. The infectious disease consul-
tant recommended intravenous nafcillin sodium therapy after sen-
sitivities were confirmed. The condition of the hand improved
rapidly on antibiotics, but the blood cultures remained positive for
S aureus and it was recommended that the patient remain on
intravenous nafcillin sodium therapy for 6 weeks.
At the time of admission, the patient had also had sudden,
persistent loss of vision in the right eye. Examination with neu-
roophthalmology detected Roth’s spots in the right eye; magnetic
resonance imaging/angiography of the brain showed a punctate
focus of increased signal intensity within the right corona radiata,
consistent with an acute small vessel infarct. A computed tomo-
graphic (CT) angiogram showed a 60% stenosis of the right
proximal internal carotid artery, 70% stenosis of the left internal
carotid artery at the bifurcation, and 50% stenosis of the left
vertebral artery at the origin. A thrombus was visualized between
the tandem stents in the right subclavian artery, for which the
patient underwent systemic anticoagulation therapy with heparin.
Carotid duplex scan showed significant plaques in the left and right
distal common carotid arteries extending into the internal carotid
arteries, with velocities corresponding to 80% to 99% stenoses
bilaterally. Although thought indicated, carotid endarterectomy
was deferred until the infection cleared. After further work-up for
other sources of septic emboli including echocardiography, it was
ultimately decided that the visual symptoms were caused by septic
embolization from the brachiocephalic stent to the brain and right
eye, in addition to those to the right hand. The patient was
discharged on intravenous antibiotics and anticoagulation therapy
to a rehabilitation facility.
The patient was readmitted 1 day later after a 10-point fall in
hematocrit and after stools were reportedly positive for occult
blood in the rehabilitation facility, which was not duplicated on
admission. While the patient was undergoing an anemia work-up,
progressively worsening stridor developed. A chest radiograph
showed tracheal deviation to the left, and fiberoptic direct laryn-
goscopy showed a paralyzed vocal cord. CT scan of the neck and
chest revealed a large, ill-defined homogeneous mass measuring
5  3 cm adjacent to the right brachiocephalic artery stent de-
scending into the anterior mediastinum consistent with a mycotic
aneurysm with surrounding hematoma (Fig 2). Immediate opera-
tive removal of the infected stent with reconstruction was under-
taken.
During an approximately 12-hour procedure in which the
patient was placed on cardiopulmonary bypass and cooled to
approximately 18° C, the infected, aneurysmal area of the brachio-
cephalic at its origin from the aorta was located. A hole 3 cm in
diameter was present, through which the free-floating stent was
easily removed (Fig 3). Despite efforts at reconstruction with
Fig 1. A, Arteriogram from January 2001 shows 75% stenosis of
proximal right subclavian artery, with 30% stenosis more distally
and 65% stenosis in brachiocephalic artery at its origin from aortic
arch. B, Arteriogram from July 2001 shows restenosis of tandem
10  40 mm Smart stents in subclavian artery and Palmaz 294
stent in brachiocephalic artery at its origin.
Fig 2. CT scan of chest reveals large, ill-defined homogeneous
mass measuring 5  3 cm adjacent to right brachiocephalic artery
stent descending into anterior mediastinum consistent with my-
cotic aneurysm with surrounding hematoma.
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maintenance of adequate cerebral perfusion, the patient became
difficult to ventilate after receiving massive amounts of blood and
blood products. The tissues became markedly edematous, making
chest closure impossible. Acute right heart failure subsequently
developed, and the patient died in the operating room.
DISCUSSION
Endovascular metallic stents are being used with in-
creasing frequency as an alternative to open operative in-
tervention for vascular disease. Generally, infection of the
artery in association with stents is considered a rare occur-
rence. In early multicenter trials by Palmaz et al9 involving
587 procedures, no infections were documented, and
Myles et al3 have reported an estimated incidence rate of
less than one in 10,000 cases. Reports of infectious com-
plications of stents in the iliac, renal, subclavian, and coro-
nary arteries and central veins have been surfacing recently,
often with fatal consequences.1-8 Iliac artery stents seem to
have the highest rate of infection,3 with access via the
femoral artery the most common route of entry for place-
ment. Possible contributory factors to infection of stents
include prolonged femoral access (specifically, the sheath
left in place overnight for follow-up angiography), repeated
access or manipulation, or another source of coincident
bacteremia, such as an infected intravenous site.1,4 S aureus
is by far the most common offending agent,1,2,4-8,10 with
Staphyloccocus epidermidis and Pseudomonas aeruginosa oc-
curring much less often. Patient presentation characteristi-
cally involves fever, leukocytosis, and bacteremia, with oc-
casional septic petechiae in the involved extremity or a focal
painful mass associated with a pseudoaneurysm, and rarely
limb ischemia.4 These symptoms generally present within 1
to 2 weeks after initial placement of the stents, suggesting
contamination of the stent during its initial placement, or
after repeat intravascular manipulation, as in the case pre-
sented herein. Initial treatment includes intravenous anti-
biotics, preferably vancomycin hydrochloride, until sensi-
tivities return. Usually, the S aureus is pansensitive, and the
patient is converted to intravenous nafcillin sodium therapy
for an average course of 6 weeks. Reports vary concerning
administration of extended oral antibiotic coverage after
treatment of the acute infection, as do recommendations
regarding the frequency of follow-up studies, such as serial
imaging with CT scans or angiography when mycotic
pseudoaneurysms or true aneurysms have developed.3
Treatment for this potentially devastating condition
has not yet been standardized. It remains unclear when to
pursue conservative medical therapy with intravenous anti-
biotics versus surgical intervention for removal of the in-
fected hardware and vascular reconstruction. Several re-
ports2,3,5 describe successful treatment with resolution of S
aureus bacteremia with antibiotic therapy alone. However,
other contributors describe formation of mycotic pseudoa-
neurysms with subsequent fatal rupture,2,4,6 encouraging a
more aggressive approach with operation earlier rather than
later. As this case illustrates, even extensive surgical inter-
vention may fail to result in survival. In general, develop-
ment of a pseudoaneurysm precedes arterial rupture and
should be an indication for urgent surgical repair if the
condition is correctly diagnosed.
The issue of prophylactic antibiotics also remains open
to debate. Although Myles et al3 suggest that the preva-
lence of stent-associated infections remains low enough
that prophylactic antibiotics are not indicated, others who
have experienced the devastating morbidity of an infectious
complication would recommend antibiotics at the time of
stent placement and during repeat manipulations and pos-
sibly during any procedure that may incur transient bacte-
remia or place the patient at higher risk (such as a sheath left
in place overnight). This suggestion is supported by studies
in a swine model, in which a 70% infection rate occurred
when a bacterial challenge was given at the time of deploy-
ment and a 50% rate when given 28 days later.10 This study
showed that prophylactic antibiotics at the time of stent
placement significantly reduce the incidence of stent infec-
tions, although it also suggested that once the stent has
been incorporated, prophylactic antibiotics should not be
necessary.
This case shows that placement of stents in difficult to
reach locations predisposes to a more serious outcome
should the stent become infected. With this in mind, the
use of periprocedural prophylactic antibiotics should be
highly encouraged in such situations.
In conclusion, metallic endovascular stents have the
potential for infection, possibly with devastating morbidity
and mortality. Prophylactic antibiotics should be used at
the time of insertion, particularly when the groin will be
accessed for a prolonged period or the stents are being
placed in a difficult to access area. Should infection occur,
intravenous antibiotics must be instituted. However, if
infection is associated with mycotic aneurysm formation,
surgical intervention for removal and reconstruction
should be pursued promptly. Finally, serial imaging is vi-
tally important in patients treated both medically and sur-
gically to detect late aneurysmal formation at the site of
former infection.
Fig 3. Intraoperative photo shows defect in aorta at takeoff of
brachiocephalic artery after removal of infected pseudoaneurysm
and stent.
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